Last reviewed · How we verify
NCT05098249
Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia
Phase 4 trial testing Verum in Anemia in 92 participants. Completed in 23 May 2023.
9 May 2023
Quick facts
| Lead sponsor | Donat R. Spahn |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 92 |
| Start date | 11 November 2021 |
| Primary completion | 9 May 2023 |
| Estimated completion | 23 May 2023 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Verum — full drug profile →
- Placebo
Conditions studied
- Anemia — all drugs for Anemia →
- Iron-deficiency — all drugs for Iron-deficiency →
- Hypophosphatemia — all drugs for Hypophosphatemia →
Sponsor
Donat R. Spahn — full company profile →
Who can join
18 and older, any sex, with Anemia or Iron-deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a confirmatory trial to establish superior serum phosphate stability associated with use of Phoscap® compared with placebo as a supplement for treatment of iron deficiency or iron deficiency anemia with Ferinject® before elective surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05098249
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Verum
Trials testing the same drug.
- NCT07017244 — Effect of a Dietary Supplement vs Low-dosage Product on Infant Gastrointestinal Discomfort and Colics · NA · not yet recruiting
- NCT06123234 — Randomised Double-blind Active vs. Placebo Clinical Trial on the Effect of a Food Supplement on IBS in Children · NA · unknown
- NCT05598749 — Poplar-type Propolis Dry Extract ESIT12 : Immunomodulation Efficacy Study · NA · completed
- NCT06218225 — Effect of an Immune-boosting Food Supplement on the Severity and Frequency of Pediatric Respiratory Tract Infections · NA · completed
- NCT05472285 — Evaluation of the Effects of a Food Supplementation on the Improvement of Cognitive Functions in Healthy Seniors · NA · completed
Other recruiting trials for Anemia
Currently open trials in the same condition.
- NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
- NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
- NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
- NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
- NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05098249 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Donat R. Spahn
- Last refreshed: 24 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05098249.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing